Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-03-18
2009-11-24
Morris, Patricia L (Department: 1625)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
active
07622588
ABSTRACT:
The present invention provides a method for preparing a substantially pure lansoprazole containing less than about 0.2% (wt/wt) impurities including sulfone/sulfide derivatives. The present invention also provides a process for recrystallizing lansoprazole to obtain a lansoprazole containing less than about 0.1% (wt/wt) water.
REFERENCES:
patent: 4628098 (1986-12-01), Nohara et al.
patent: 4689333 (1987-08-01), Nohara et al.
patent: 5026560 (1991-06-01), Makino et al.
patent: 5045321 (1991-09-01), Makino et al.
patent: 5093132 (1992-03-01), Makino et al.
patent: 5433959 (1995-07-01), Makino et al.
patent: 5578732 (1996-11-01), Kato et al.
patent: 6002011 (1999-12-01), Kato et al.
patent: 6166213 (2000-12-01), Anousis et al.
patent: 6180652 (2001-01-01), Tsujii et al.
patent: 6268502 (2001-07-01), Milac et al.
patent: 6313303 (2001-11-01), Tagami et al.
patent: 2003/0036554 (2003-02-01), Avrutov et al.
patent: 2004/0138466 (2004-07-01), Avrutov et al.
patent: 2 063 705 (1995-01-01), None
patent: 2 105 953 (1997-10-01), None
patent: WO 99/47514 (1999-09-01), None
patent: 01/21617 (2001-03-01), None
patent: WO 01/21617 (2001-03-01), None
patent: WO 01/68594 (2001-09-01), None
Vrecer et al., “Study of Influence, etc.,” Farmacevski Vestnik (Lubljana) 1997, 48, pp. 242-243.
Kotar et al., “Study of Polymorphism, etc.,” Eur. J. Of Pharm. Sci., 1996, 4, pS182).
Haleblian et al., “Pharmaceutical Applications, etc.,” J of Pharm. Sci., 1969, 58(8), 911-929.
Chemical & Engineering News, Feb. 2003, 32-35.
US Pharmacopia #23, National Formulary #18 (1995) 1843-1844.
Muzaffar et al., “ Polymorphism and , etc.,” J. Of Pharm. (Lahore) 1979, 1(1), 59-66.
Jain et al., “ Polymorphism in Pharmacy”, Indian Drugs, 1986, 23(6) , 315-329.
Concise Encyclopedia Chemistry, NY: Walter de Gryter, 1994, 872-873.
Britttain et al., “Polymorphism in Pharmaceutical Solids” NY: Marcel Dekker, Inc. 1999, pp. 1-2, 185.
The United States Pharmacopeial Convention, Inc., Pharmacopeial Forum vol. 26 No. 5., pp. 1229-1232.; 2000.
Drug Development and Industrial Pharmacy Stabilization of a New Antiulcer Drug (Lansoprazole) in the Solid Dosage Forms, pp. 1437-1447, 1992.
Finkelstein Nina
Liberman Anita
Nidam Tamar
Singer Claude
Veinberg Irena
Kenyon & Kenyon LLP
Morris Patricia L
Teva Pharmaceutical Industries Ltd.
LandOfFree
Method for the purification of lansoprazole does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for the purification of lansoprazole, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for the purification of lansoprazole will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4135811